Table 4.

Patient, tumor and provider characteristics by overall treatment adherence.

Characteristics	Treatment plan non-adherence (n = 4157, 76%)		Treatment plan adherence (n = 1288, 24%)		Chi square test p-value
	n	%	n	%
Race					<0.0001
White	2679	75.7	861	24.3
African American	168	79.6	43	20.4
Hispanic	737	81.6	166	18.4
Asian/Pacific Islander	573	72.4	218	27.6
Insurance					<0.0001
Managed care	2174	74.1	758	25.9
Medicare	895	84.4	166	15.6
Medicaid	359	79.1	95	20.9
Other ins	568	71.0	232	29.0
Not insured	161	81.3	37	18.7
SES					<0.0001
Lowest SES	561	83.6	110	16.4
Lower-middle SES	807	81.0	189	19.0
Middle SES	924	77.6	266	22.4
Higher-middle SES	961	75.8	306	24.2
Highest SES	904	68.4	417	31.6
Age					<0.0001
<45	967	75.3	317	24.7
45–54	1085	73.2	398	26.8
55–69	1098	71.9	429	28.1
> = 70	1007	87.5	144	12.5
Stage					0.9629
I	3014	76.4	933	23.6
II	1143	76.3	355	23.7
Grade					<0.0001
Grade I	746	74.1	261	25.9
Grade II	935	67.4	452	32.6
Grade III	969	76.2	303	23.8
Grade IV	252	71.0	103	29.0
Grade not stated	1255	88.1	169	11.9
Histology					<0.0001
Serous	926	77.9	262	22.1
Mucinous	595	73.8	211	26.2
Endometrioid	944	71.8	370	28.2
Clear cell	437	69.9	188	30.1
Adenocarcinoma, NOS	252	89.7	29	10.3
Other	1003	81.5	228	18.5
Tumor size					<0.0001
≤5 cm	638	79.3	167	20.7
5–10 cm	815	74.8	275	25.2
>10 cm	1346	73.0	499	27.0
Unknown	1358	79.6	347	20.4
Hospital volume					<0.0001
High volume	655	67.0	322	33.0
Low volume	3502	78.4	966	21.6
Hospital type					<0.0001
ACoS approved	1301	73.2	477	26.8
Not ACoS approved	1624	74.1	568	25.9
Unknown	1232	83.5	243	16.5
Physician volume					<0.0001
High volume	610	70.2	259	29.8
Low volume	2712	77.9	768	22.1
Physician unknown	835	76.2	261	23.8